Efficacy of Dalfampridine on visual function (contrast sensitivity). 8 weeks [clinicaltrials_resource:4613fb2f8d73de69589edf000a5c4180]
Dalfampridine treatment will improve visual function, measured by the 5% ETDRS contrast sensitivity chart, in subjects with long-term visual impairment secondary to optic neuritis from MS.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Efficacy of Dalfampridine on visual function (contrast sensitivity). 8 weeks [clinicaltrials_resource:4613fb2f8d73de69589edf000a5c4180]
Dalfampridine treatment will improve visual function, measured by the 5% ETDRS contrast sensitivity chart, in subjects with long-term visual impairment secondary to optic neuritis from MS.
Bio2RDF identifier
4613fb2f8d73de69589edf000a5c4180
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4613fb2f8d73de69589edf000a5c4180
measure [clinicaltrials_vocabulary:measure]
Efficacy of Dalfampridine on visual function (contrast sensitivity).
time frame [clinicaltrials_vocabulary:time-frame]
description
Dalfampridine treatment will i ...... ary to optic neuritis from MS.
identifier
clinicaltrials_resource:4613fb2f8d73de69589edf000a5c4180
title
Efficacy of Dalfampridine on visual function (contrast sensitivity). 8 weeks
@en
type
label
Efficacy of Dalfampridine on v ...... 3fb2f8d73de69589edf000a5c4180]
@en